BRYAN BURT to Biomarkers, Tumor
This is a "connection" page, showing publications BRYAN BURT has written about Biomarkers, Tumor.
Connection Strength
1.457
-
Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma. Ann Thorac Surg. 2021 11; 112(5):1575-1583.
Score: 0.375
-
Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. Ann Thorac Surg. 2017 Nov; 104(5):1679-1687.
Score: 0.301
-
Improved detection of stage I non-small cell lung cancer with a serum-based assay. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):735-6.
Score: 0.248
-
Gene expression in tumor and adjacent normal tissues in lung adenocarcinoma subtypes. BMC Cancer. 2025 Jul 14; 25(1):1169.
Score: 0.129
-
Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1082-1095.e4.
Score: 0.123
-
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling. Mol Cancer Ther. 2021 08; 20(8):1469-1480.
Score: 0.097
-
Matrix metalloproteinase 12 promotes tumor propagation in the lung. J Thorac Cardiovasc Surg. 2018 05; 155(5):2164-2175.e1.
Score: 0.077
-
Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol. 2014 Feb; 41(1):40-56.
Score: 0.058
-
A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma. Br J Cancer. 2022 11; 127(9):1691-1700.
Score: 0.026
-
Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors. J Thorac Cardiovasc Surg. 2020 04; 159(4):1598-1610.e3.
Score: 0.022